help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ferrara, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ferrara, N.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Endocrine Reviews 25 (4): 581-611
Copyright © 2004 by The Endocrine Society

Vascular Endothelial Growth Factor: Basic Science and Clinical Progress

Napoleone Ferrara

Department of Molecular Oncology, Genentech, Inc., South San Francisco, California 94080

Correspondence: Address all correspondence and requests for reprints to: Napoleone Ferrara, M.D., Department of Molecular Oncology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080. E-mail: nf{at}gene.com

Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen in vitro and an angiogenic inducer in a variety of in vivo models. Hypoxia has been shown to be a major inducer of VEGF gene transcription. The tyrosine kinases Flt-1 (VEGFR-1) and Flk-1/KDR (VEGFR-2) are high-affinity VEGF receptors. The role of VEGF in developmental angiogenesis is emphasized by the finding that loss of a single VEGF allele results in defective vascularization and early embryonic lethality. VEGF is critical also for reproductive and bone angiogenesis. Substantial evidence also implicates VEGF as a mediator of pathological angiogenesis. In situ hybridization studies demonstrate expression of VEGF mRNA in the majority of human tumors. Anti-VEGF monoclonal antibodies and other VEGF inhibitors block the growth of several tumor cell lines in nude mice. Clinical trials with various VEGF inhibitors in a variety of malignancies are ongoing. Very recently, an anti-VEGF monoclonal antibody (bevacizumab; Avastin) has been approved by the Food and Drug Administration as a first-line treatment for metastatic colorectal cancer in combination with chemotherapy. Furthermore, VEGF is implicated in intraocular neovascularization associated with diabetic retinopathy and age-related macular degeneration.




This article has been cited by other articles:


Home page
 VASC ENDOVASCULAR SURGHome page
D. M. Birk, J. Barbato, L. Mureebe, and R. A. Chaer
Basic Science Review: Current Insights on the Biology and Clinical Aspects of VEGF Regulation
Vascular and Endovascular Surgery, December 1, 2009; 42(6): 517 - 530.
[Abstract] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Coxon, T. Bush, D. Saffran, S. Kaufman, B. Belmontes, K. Rex, P. Hughes, S. Caenepeel, J. B. Rottman, A. Tasker, et al.
Broad Antitumor Activity in Breast Cancer Xenografts by Motesanib, a Highly Selective, Oral Inhibitor of Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor, and Kit Receptors
Clin. Cancer Res., January 1, 2009; 15(1): 110 - 118.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
F. Y.F. Lee, K. L. Covello, S. Castaneda, D. R. Hawken, D. Kan, A. Lewin, M.-L. Wen, R.-P. Ryseck, C. R. Fairchild, J. Fargnoli, et al.
Synergistic Antitumor Activity of Ixabepilone (BMS-247550) Plus Bevacizumab in Multiple In vivo Tumor Models
Clin. Cancer Res., December 15, 2008; 14(24): 8123 - 8131.
[Abstract] [Full Text] [PDF]

Home page
 J. Dent. Res.Home page
E.M. Mullane, Z. Dong, C.M. Sedgley, J.C.-C. Hu, T.M. Botero, G.R. Holland, and J.E. Nor
Effects of VEGF and FGF2 on the Revascularization of Severed Human Dental Pulps
J. Dent. Res., December 1, 2008; 87(12): 1144 - 1148.
[Abstract] [Full Text] [PDF]

Home page
 FAKE JDRHome page
E.M. Mullane, Z. Dong, C.M. Sedgley, J.C.-C. Hu, T.M. Botero, G.R. Holland, and J.E. Nor
Effects of VEGF and FGF2 on the Revascularization of Severed Human Dental Pulps
Journal of Dental Research, December 1, 2008; 87(12): 1144 - 1148.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
S. B. Long, M. B. Long, R. R. White, and B. A. Sullenger
Crystal structure of an RNA aptamer bound to thrombin
RNA, December 1, 2008; 14(12): 2504 - 2512.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. W. Aberdeen, S. J. Wiegand, T. W. Bonagura Jr., G. J. Pepe, and E. D. Albrecht
Vascular Endothelial Growth Factor Mediates the Estrogen-Induced Breakdown of Tight Junctions between and Increase in Proliferation of Microvessel Endothelial Cells in the Baboon Endometrium
Endocrinology, December 1, 2008; 149(12): 6076 - 6083.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Gelati, A. C. Aplin, E. Fogel, K. D. Smith, and R. F. Nicosia
The Angiogenic Response of the Aorta to Injury and Inflammatory Cytokines Requires Macrophages
J. Immunol., October 15, 2008; 181(8): 5711 - 5719.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D. Pereg and M. Lishner
Bevacizumab treatment for cancer patients with cardiovascular disease: a double edged sword?
Eur. Heart J., October 1, 2008; 29(19): 2325 - 2326.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
S. Piermarocchi, M. Sartore, G. Lo Giudice, V. Maritan, E. Midena, and T. Segato
Combination of Photodynamic Therapy and Intraocular Triamcinolone for Exudative Age-Related Macular Degeneration and Long-Term Chorioretinal Macular Atrophy
Arch Ophthalmol, October 1, 2008; 126(10): 1367 - 1374.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Hlushchuk, O. Riesterer, O. Baum, J. Wood, G. Gruber, M. Pruschy, and V. Djonov
Tumor Recovery by Angiogenic Switch from Sprouting to Intussusceptive Angiogenesis after Treatment with PTK787/ZK222584 or Ionizing Radiation
Am. J. Pathol., October 1, 2008; 173(4): 1173 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. M. Elias, J. Arbiser, B. E. Brown, H. Rossiter, M.-Q. Man, F. Cerimele, D. Crumrine, R. Gunathilake, E. H. Choi, Y. Uchida, et al.
Epidermal Vascular Endothelial Growth Factor Production Is Required for Permeability Barrier Homeostasis, Dermal Angiogenesis, and the Development of Epidermal Hyperplasia: Implications for the Pathogenesis of Psoriasis
Am. J. Pathol., September 1, 2008; 173(3): 689 - 699.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
R Karanjia, K T Eng, J Gale, S Sharma, and M W t. Hove
Electrophysiological effects of intravitreal Avastin (bevacizumab) in the treatment of exudative age-related macular degeneration
Br. J. Ophthalmol., September 1, 2008; 92(9): 1248 - 1252.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Qu, S. Van Ginkel, A. M. Roy, L. Westbrook, M. Nasrin, Y. Maxuitenko, A. R. Frost, D. Carey, W. Wang, R. Li, et al.
Vascular Endothelial Growth Factor Reduces Tamoxifen Efficacy and Promotes Metastatic Colonization and Desmoplasia in Breast Tumors
Cancer Res., August 1, 2008; 68(15): 6232 - 6240.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. M. Jay, B. R. Shepherd, J. P. Bertram, J. S. Pober, and W. M. Saltzman
Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation
FASEB J, August 1, 2008; 22(8): 2949 - 2956.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
C. M. Findley, R. G. Mitchell, B. D. Duscha, B. H. Annex, and C. D. Kontos
Plasma Levels of Soluble Tie2 and Vascular Endothelial Growth Factor Distinguish Critical Limb Ischemia From Intermittent Claudication in Patients With Peripheral Arterial Disease
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 387 - 393.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
M. H. Criswell, W.-Z. Hu, T. J. Steffens, R. Li, and P. Margaron
Comparing Pegaptanib and Triamcinolone Efficacy in the Rat Choroidal Neovascularization Model
Arch Ophthalmol, July 1, 2008; 126(7): 946 - 952.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
W. C. Duncan, S. van den Driesche, and H. M. Fraser
Inhibition of Vascular Endothelial Growth Factor in the Primate Ovary Up-Regulates Hypoxia-Inducible Factor-1{alpha} in the Follicle and Corpus Luteum
Endocrinology, July 1, 2008; 149(7): 3313 - 3320.
[Abstract] [Full Text] [PDF]

Home page
 Cereb CortexHome page
H. Bengoetxea, E. G. Argandona, and J. V. Lafuente
Effects of Visual Experience on Vascular Endothelial Growth Factor Expression during the Postnatal Development of the Rat Visual Cortex
Cereb Cortex, July 1, 2008; 18(7): 1630 - 1639.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M.-C. Lauzier, G. A. Robitaille, D. A. Chan, A. J. Giaccia, and D. E. Richard
(2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide (BiPS), a Matrix Metalloprotease Inhibitor, Is a Novel and Potent Activator of Hypoxia-Inducible Factors
Mol. Pharmacol., July 1, 2008; 74(1): 282 - 288.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. M. Gustafsdottir, S. Wennstrom, S. Fredriksson, E. Schallmeiner, A. D. Hamilton, S. M. Sebti, and U. Landegren
Use of Proximity Ligation to Screen for Inhibitors of Interactions between Vascular Endothelial Growth Factor A and Its Receptors
Clin. Chem., July 1, 2008; 54(7): 1218 - 1225.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Funahashi, S. L. Hernandez, I. Das, A. Ahn, J. Huang, M. Vorontchikhina, A. Sharma, E. Kanamaru, V. Borisenko, D. M. DeSilva, et al.
A Notch1 Ectodomain Construct Inhibits Endothelial Notch Signaling, Tumor Growth, and Angiogenesis
Cancer Res., June 15, 2008; 68(12): 4727 - 4735.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
O. Tatar, E. Yoeruek, P. Szurman, K. U. Bartz-Schmidt, A. Adam, K. Shinoda, C. Eckardt, V. Boeyden, C. Claes, G. Pertile, et al.
Effect of Bevacizumab on Inflammation and Proliferation in Human Choroidal Neovascularization
Arch Ophthalmol, June 1, 2008; 126(6): 782 - 790.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
W. Cai and X. Chen
Multimodality Molecular Imaging of Tumor Angiogenesis
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 113S - 128S.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
H Deissler, H Deissler, S Lang, and G E Lang
VEGF-induced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells
Br. J. Ophthalmol., June 1, 2008; 92(6): 839 - 843.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
B. Sung, M. K. Pandey, K. S. Ahn, T. Yi, M. M. Chaturvedi, M. Liu, and B. B. Aggarwal
Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-{kappa}B-regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-{kappa}B{alpha} kinase, leading to potentiation of apoptosis
Blood, May 15, 2008; 111(10): 4880 - 4891.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Z.-L. Wang, X.-P. Xu, B.-L. He, S.-P. Weng, J. Xiao, L. Wang, T. Lin, X. Liu, Q. Wang, X.-Q. Yu, et al.
Infectious Spleen and Kidney Necrosis Virus ORF48R Functions as a New Viral Vascular Endothelial Growth Factor
J. Virol., May 1, 2008; 82(9): 4371 - 4383.
[Abstract] [Full Text] [PDF]

Home page
 GlycobiologyHome page
H.-J. Choi, T.-W. Chung, S.-J. Kim, S.-Y. Cho, Y.-S. Lee, Y.-C. Lee, J.-H. Ko, and C.-H. Kim
The AP-2{alpha} transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene
Glycobiology, May 1, 2008; 18(5): 395 - 407.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. J. P. Deudero, C. Caramelo, M. C. Castellanos, F. Neria, R. Fernandez-Sanchez, O. Calabia, S. Penate, and F. R. Gonzalez-Pacheco
Induction of Hypoxia-inducible Factor 1{alpha} Gene Expression by Vascular Endothelial Growth Factor
J. Biol. Chem., April 25, 2008; 283(17): 11435 - 11444.
[Abstract] [Full Text] [PDF]

Home page
 aacredbookHome page
M. Kowanetz and N. Ferrara
Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective
Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 173 - 181.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
Y. Sato
VEGFR1 for Lymphangiogenesis: An Alternative Signaling Pathway?
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 604 - 605.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
G. M. Tozer, S. Akerman, N. A. Cross, P. R. Barber, M. A. Bjorndahl, O. Greco, S. Harris, S. A. Hill, D. J. Honess, C. R. Ireson, et al.
Blood Vessel Maturation and Response to Vascular-Disrupting Therapy in Single Vascular Endothelial Growth Factor-A Isoform-Producing Tumors
Cancer Res., April 1, 2008; 68(7): 2301 - 2311.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
A. Bastide, Z. Karaa, S. Bornes, C. Hieblot, E. Lacazette, H. Prats, and C. Touriol
An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform
Nucleic Acids Res., April 1, 2008; 36(7): 2434 - 2445.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Song, J. Kim, F. W. Bazer, and T. E. Spencer
Progesterone and Interferon Tau Regulate Hypoxia-Inducible Factors in the Endometrium of the Ovine Uterus
Endocrinology, April 1, 2008; 149(4): 1926 - 1934.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Gutierrez, G. E. Konecny, K. Hong, A. Burges, T. D. Henry, P. D. Lambiase, W. Lee Wong, and Y. G. Meng
A New ELISA for Use in a 3-ELISA System to Assess Concentrations of VEGF Splice Variants and VEGF110 in Ovarian Cancer Tumors
Clin. Chem., March 1, 2008; 54(3): 597 - 601.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. K. Willmann, K. Chen, H. Wang, R. Paulmurugan, M. Rollins, W. Cai, D. S. Wang, I. Y. Chen, O. Gheysens, M. Rodriguez-Porcel, et al.
Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography
Circulation, February 19, 2008; 117(7): 915 - 922.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Kubo, T.-S. Li, R. Suzuki, B. Shirasawa, N. Morikage, M. Ohshima, S.-L. Qin, and K. Hamano
Hypoxic preconditioning increases survival and angiogenic potency of peripheral blood mononuclear cells via oxidative stress resistance
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H590 - H595.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Calvani, D. Trisciuoglio, C. Bergamaschi, R. H. Shoemaker, and G. Melillo
Differential Involvement of Vascular Endothelial Growth Factor in the Survival of Hypoxic Colon Cancer Cells
Cancer Res., January 1, 2008; 68(1): 285 - 291.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncolHome page
I. Fischer, C. H. Cunliffe, R. J. Bollo, S. Raza, D. Monoky, L. Chiriboga, E. C. Parker, J. G. Golfinos, P. J. Kelly, E. A. Knopp, et al.
High-grade glioma before and after treatment with radiation and Avastin: Initial observations
Neuro-oncol, January 1, 2008; 10(5): 700 - 708.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. H. Thomas, H. Wilson, A. Silvestri, and H. M. Fraser
Thrombospondin-1 Expression Is Increased during Follicular Atresia in the Primate Ovary
Endocrinology, January 1, 2008; 149(1): 185 - 192.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Korsisaari, J. Ross, X. Wu, M. Kowanetz, N. Pal, L. Hall, J. Eastham-Anderson, W. F. Forrest, N. Van Bruggen, F. V. Peale, et al.
Blocking Vascular Endothelial Growth Factor-A Inhibits the Growth of Pituitary Adenomas and Lowers Serum Prolactin Level in a Mouse Model of Multiple Endocrine Neoplasia Type 1
Clin. Cancer Res., January 1, 2008; 14(1): 249 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Zhang, N. Dmitrieva, Y. Liu, K. A. McGinty, and K. J. Berkley
Endometriosis as a neurovascular condition: estrous variations in innervation, vascularization, and growth factor content of ectopic endometrial cysts in the rat
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R162 - R171.
[Abstract] [Full Text] [PDF]

Home page
 Exp PhysiolHome page
C. Liu, G. M. Balanos, M. Fatemian, T. G. Smith, K. L. Dorrington, and P. A. Robbins
Effects of hydralazine on the pulmonary vasculature and respiratory control in humans
Exp Physiol, January 1, 2008; 93(1): 104 - 114.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
H. Rossiter, C. Barresi, M. Ghannadan, F. Gruber, M. Mildner, D. Fodinger, and E. Tschachler
Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function
FASEB J, December 1, 2007; 21(14): 3994 - 4004.
[Abstract] [Full Text] [PDF]

Home page
 Poult. Sci.Home page
N. C. Rath, W. E. Huff, and G. R. Huff
Thiram-Induced Changes in the Expression of Genes Relating to Vascularization and Tibial Dyschondroplasia
Poult. Sci., November 1, 2007; 86(11): 2390 - 2395.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
K. Fizazi
The role of Src in prostate cancer
Ann. Onc., November 1, 2007; 18(11): 1765 - 1773.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
H. Izuta, Y. Chikaraishi, M. Shimazawa, S. Mishima, and H. Hara
10-Hydroxy-2-decenoic Acid, a Major Fatty Acid from Royal Jelly, Inhibits VEGF-induced Angiogenesis in Human Umbilical Vein Endothelial Cells
Evid. Based Complement. Altern. Med., October 22, 2007; (2007) nem152v1.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. B. Saltz, H.-J. Lenz, H. L. Kindler, H. S. Hochster, S. Wadler, P. M. Hoff, N. E. Kemeny, E. M. Hollywood, M. Gonen, M. Quinones, et al.
Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 Study
J. Clin. Oncol., October 10, 2007; 25(29): 4557 - 4561.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
J. Klubo-Gwiezdzinska, R. Junik, E. Kopczynska, O. Juraniec, and H. Kardymowicz
The comparison of serum vascular endothelial growth factor levels between patients with metastatic and non-metastatic thyroid cancer, and patients with nontoxic multinodular goiter
Eur. J. Endocrinol., October 1, 2007; 157(4): 521 - 527.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
T. Ostendorf, A. S. De Vriese, and J. Floege
Renal side effects of anti-VEGF therapy in man: a new test system
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2778 - 2780.
[Full Text] [PDF]

Home page
 Arch OphthalmolHome page
O. Sawada, H. Kawamura, M. Kakinoki, T. Sawada, and M. Ohji
Vascular Endothelial Growth Factor in Aqueous Humor Before and After Intravitreal Injection of Bevacizumab in Eyes With Diabetic Retinopathy
Arch Ophthalmol, October 1, 2007; 125(10): 1363 - 1366.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Krilleke, A. DeErkenez, W. Schubert, I. Giri, G. S. Robinson, Y.-S. Ng, and D. T. Shima
Molecular Mapping and Functional Characterization of the VEGF164 Heparin-binding Domain
J. Biol. Chem., September 21, 2007; 282(38): 28045 - 28056.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
F. A. Scappaticci, J. R. Skillings, S. N. Holden, H.-P. Gerber, K. Miller, F. Kabbinavar, E. Bergsland, J. Ngai, E. Holmgren, J. Wang, et al.
Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab
J Natl Cancer Inst, August 15, 2007; 99(16): 1232 - 1239.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
A. Silvestri and H. M Fraser
Oestrogen and progesterone receptors in the marmoset endometrium: changes during the ovulatory cycle, early pregnancy and after inhibition of vascular endothelial growth factor, GnRH or ovariectomy
Reproduction, August 1, 2007; 134(2): 341 - 353.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
W. B. Nagengast, E. G. de Vries, G. A. Hospers, N. H. Mulder, J. R. de Jong, H. Hollema, A. H. Brouwers, G. A. van Dongen, L. R. Perk, and M. N. Lub-de Hooge
In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft
J. Nucl. Med., August 1, 2007; 48(8): 1313 - 1319.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R Zhai, M N Gong, W Zhou, T B Thompson, P Kraft, L Su, and D C Christiani
Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS
Thorax, August 1, 2007; 62(8): 718 - 722.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
D. J. Kelly, D. Buck, A. J. Cox, Y. Zhang, and R. E. Gilbert
Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy
Am J Physiol Renal Physiol, August 1, 2007; 293(2): F565 - F574.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
M. Luke, K. Januschowski, M. Warga, J. Beutel, M. Leitritz, F. Gelisken, S. Grisanti, T. Schneider, C. Luke, K. U. Bartz-Schmidt, et al.
The retinal tolerance to bevacizumab in co-application with a recombinant tissue plasminogen activator
Br. J. Ophthalmol., August 1, 2007; 91(8): 1077 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 DTBHome page
A view on new drugs for macular degeneration
DTB, July 1, 2007; 45(7): 49 - 52.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. H. Chidlow Jr., D. Shukla, M. B. Grisham, and C. G. Kevil
Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues
Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G5 - G18.
[Abstract] [Full Text] [PDF]